At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
XPH Spdr S&P Pharmaceuticals Etf
Closed 07-27 16:00:00 EDT
68.54
+0.59
+0.87%
盘后68.34
-0.20-0.29%
19:34 EDT
High69.63Low68.31Vol187.76K
Open68.48D1 Closing67.95Amplitude1.94%
Mkt Cap479.80MTradable Cap479.80MTotal Shares7.00M
T/O12.92MT/O Rate2.68%Tradable Shares7.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

HENLIUS Initiates First Patient Dosing in China for Phase 1 Study of Cetuximab Biosimilar HLX05-N in Metastatic Colorectal Cancer
Stock News  ·  07-08
HENLIUS Initiates First Patient Dosing in China for Phase 1 Study of Cetuximab Biosimilar HLX05-N in Metastatic Colorectal Cancer

Introduction

Company Name.
Spdr S&P Pharmaceuticals Etf
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
Issue price:
--